相关实验视频

Updated: May 8, 2026

Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI

Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI

Published on: November 1, 2014

对猫的过敏:当前的前景和治疗选择

Pascal Demoly¹, Myriam Zakariya², Ignacio Dávila^3,4,5

¹University Hospital of Montpellier and IDESP, University Hospital of Montpellier-INSERM-INRIA PreMediCal, Montpellier, France.

Clinical and translational allergy

|March 3, 2026

概括

猫毛过敏症,包括过敏性鼻炎 (AR) 和喘,影响全球许多人. 过敏原免疫疗法 (AIT) 是有前途的,但需要改进的配方和个性化的方法,以获得更好的结果.

科学领域:

免疫学免疫学免疫学
过敏学过敏学
环境健康环境健康

背景情况:

猫毛皮过敏原导致显著的过敏性鼻炎 (AR) 和喘,在全球范围内患病率很高.
对 Fel d 1 和 Fel d 4 等猫过敏原的暴露是普遍的,甚至影响到非猫主.
目前通过避免和药物治疗进行的治疗往往不足以治疗严重病例.

研究的目的:

审查当前猫类过敏原免疫疗法 (AIT) 的现状.
探索AIT在猫引起的过敏疾病方面的挑战和进展.
突出需要改进AIT策略和个性化治疗.

主要方法:

关于猫的过敏原和免疫治疗方法的文献综述.
对AIT疗效和处方率的现有挑战进行分析.
探索新的AIT配方和辅助疗法.

主要成果:

Fel d 1 和 Fel d 4 是猫引起的喘和AR中的关键过敏原.
AIT (SLIT和SCIT) 提供疾病修饰,但在效力和标准化方面面临局限性.
包括Feld4和新型抗原呈现方法在内的较新的AIT配方显示出潜力.
与单克隆抗体的组合疗法可以提高AIT的有效性和安全性.

结论:

改进的AIT配方和个性化的护理对于控制猫过敏至关重要.
组件解决诊断对于将AIT定制为个别敏感性配置文件至关重要.
加强医生和患者教育对于更广泛的AIT采用和治疗成功至关重要.

关键词:

一个错误的11d.过敏原免疫疗法免疫疗法过敏性鼻炎过敏性鼻炎喘喘是一种猫过敏猫过敏猫过敏

更多相关视频

Antigenic Liposomes for Generation of Disease-specific Antibodies

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

相关概念视频

Cross-reactivity

Cross-reactivity

Allergic Reactions

Allergic Reactions

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

Drug Toxicity: Allergic Reactions

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...

Allergic Reactions: Anaphylaxis

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...